Assessing potency of c-Jun N-terminal kinase 3 (JNK3) inhibitors using 2D molecular descriptors and binary QSAR

Ismail Ijjaali1, François Petitet, Elodie Dubus

  • 1Aureus Pharma, 174 Quai de Jemmapes, Paris, France. ismail.ijjaali@aureus-pharma.com